Hawryluk P. Kent bought MBX
February 2, 2026 · Form 4 insider transaction
Hawryluk P. Kent bought 35,250 shares of MBX Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
35,250
Price
$0.00
Total value
N/A
InsiderHawryluk P. Kent
RoleOfficer, Director
CompanyMBX Biosciences, Inc. (MBX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after699,506
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the grant of restricted stock units (RSUs). The RSUs will vest over a four (4) year period in equal quarterly installments, subject to the Reporting Person's continued service on such vesting date.